Curriculum Vitae

NAME: Paige L. Williams

TITLE: Senior Lecturer on Biostatistics

ADDRESS: Office: Home:Department of Biostatistics 47 Cumberland AvenueHarvard School of Public Health Brookline, MA 02445655 Huntington Avenue (617) 277-4977Boston, MA 02115Tel: (617) 432-3872Fax: (617) 432-2832E-mail: paige@sdac.harvard.edu

Date & Place of Birth: 3/5/1961 in Hartford, CT, USA

EDUCATION:

Date Discipline Degree Institution1990 Biostatistics PhD University of North Carolina at Chapel Hill1984 Biostatistics MS University of North Carolina at Chapel Hill1983 Biostatistics BSPH University of North Carolina at Chapel Hill

ACADEMIC APPOINTMENTS:

2006 - present Senior Lecturer on Biostatistics, Harvard School of Public Health (HSPH),Boston, MA

2001 - 2005 Lecturer on Biostatistics, HSPH, Boston, MA1997 - 2001 Associate Professor of Biostatistics, HSPH, Boston, MA1991 - 1997 Assistant Professor of Biostatistics, HSPH, Boston, MA1990 Guest Scientist, German Cancer Research Center, Heidelberg, Germany1988 Visiting Lecturer, UNC Dept of Health Policy, Chapel Hill, NC

MAJOR RESEARCH INTERESTS:

Design and analysis of HIV/AIDS clinical trials and observational studies, risk assessment for can-cer and non-cancer endpoints, environmental statistics, environmental epidemiology, statisticalmethods for reproductive and developmental outcomes, survival analysis, longitudinal analysis,interim monitoring for randomized clinical trials

PROFESSIONAL AND ADMINISTRATIVE APPOINTMENTS:

2012 - 2014 Vice-Chair, Scientific Leadership Group for theU.S. Pediatric HIV/AIDS Cohort Study (PHACS) Network

2005 - present Director, Core for Biostatistics & Epidemiologic Methods (C-BEAM)for the U.S. Pediatric HIV/AIDS Cohort Study (PHACS) network, HSPH

2007 - present Co-Chair, PHACS Cardiopulmonary Working Group2007 - present Co-Chair, PHACS SMARTT Review Panel2007 - 2013 Co-Chair, PHACS Hearing/Language Working Group2007 - 2012 Co-Chair, PHACS Maternal Exposures Working Group2007 - 2010 Chair, PHACS Site Evaluation Committee2003 - present Senior Statistician, IMPAACT Statistical Center1991 - present Senior Statistician, ACTG Statistical Center1995 - 1997 Head, Complications of HIV Section, ACTG SDAC, HSPH1988 - 1989 Mathematical Statistician, NIEHS, Research Triangle Park, NC

AWARDS, GRANTS AND HONORS:

1998 James Grizzle Distinguished Alumnus Award, UNC-Chapel Hill1996 - 2001 First Independent Research Support and Transition (FIRST) Award1994 - 1995 Harvard-Schering Plough Fellowship1994 NSF Young Investigators Award1991 Bok Grant for Innovations in Teaching, HSPH

PROFESSIONAL SOCIETIES AND EDITORIAL BOARDS:

2000-2005 Reproductive Toxicology, Editorial Board1999-2002 Amstat Online, Science Editor1999-2004 Chance Magazine of the American Statistical Association, Biostatistics Editor

MAJOR DEPARTMENTAL AND UNIVERSITY SERVICE:(HSPH-wide committees and departmental committee chairs, since 2000)

2015-present Director of Graduate Studies, Biostatistics2013-2014 HSPH Faculty Council, Vice-Chair2012-2013 HSPH ad-hoc Grievance Committee, Chair2011-2014 HSPH Faculty Council, elected member1996-2011 HSPH Committee on Concerns of Women Faculty2010-2012 Chair, Biostatistics Junior Faculty Development Committee2007-2009 Chair, Biostatistics Postdoctoral Committee2003-2004 Chair, Biostatistics Teaching Effectiveness Committee2006-2007 Chair, Biostatistics Qualifying Exam Evaluation Committee2002 Chair, Myrto Lefkopoulou Award Committee2000-2001 Chair, Biostatistics Postdoctoral Committee2001 Chair, Biostatistics Seminar Committee

MAJOR PROFESSIONAL SERVICE:

2011-2015 Member, Charles H. Hood Scientific Review Committee2013 Member of Special Emphasis Panel, Review of NIH Trials for Option B+

Treatment for HIV-infected Pregnant Women2012 Member of Special Emphasis Panel, Review of NIDCR Clinical Trials2011,2015 Member of Special Emphasis Panel, Review of IeDEA grant applications2008 Expert Reviewer, National Research Council of the National Academies, Board on

Environmental Studies and Toxicology, Cumulative Risk Assessment of Phthalates2000-2007 Member, Data and Safety Monitoring Board for the NIH Vaccine Study

for Disseminated Tuberculosis in Tanzania2005-2006 Member of di(2-ethylhexyl) phthalate (DEHP) Expert Panel,

Center for the Evaluation of Risks to Human Reproduction (CERHR)2003-2004 Member, Data and Safety Monitoring Board for two Schering-Plough Research Inst.

Treatment Studies for Non-small Cell Lung Cancer2003-2004 Member of Fluoxetine (Prozac) Expert Panel, CERHR2000-2002 Elected Member of the International Biometric Society Council2000-2002 Elected Member of the ENAR Regional Executive Committee of

the International Biometric Society (IBS)1999-2000 Member of Phthalate Expert Panel, National Toxicology Program (NTP)

Center for the Evaluation of Risks to Human Reproduction1996-1998 Member of the Eastern North American Region (ENAR)

Regional Advisory Board for the IBS1998 Principal Scientist, EPA Workshop on Exposure Duration and Toxicity1998 Secretary, Environmental Statistics Section of the American Statistical Association1997 Treasurer, Environmental Statistics Section of the American Statistical Association

TEACHING EXPERIENCE:

2012-2015 Applied Survival Analysis (BIO223), HSPH2007-2009 Basics of Statistical Inference (BIO222), HSPH2003-2006 Advanced Multivariate Analysis (BIO245), HSPH1998-2000 Applied Survival Analysis (BIO223), HSPH1999 Applied Survival Analysis (3-week intensive course)

University of Athens, Greece1996, 1998 Statistical Methods for Bioassay Studies (BIO266), HSPH

Co-taught with Drs. Louise Ryan & Paul Catalano1996 Design and Analysis of Animal Bioassay Experiments (short course)

The University of Newcastle, Australia1994-1995 Discrete Data Analysis (BIO221), HSPH1991-1993 Statistical Methods for Health Policy and Management (BIH204), HSPH

Awarded Bok Grant for Innovations in Teaching.1988 Advanced Quantitative Methods for Health Policy

University of North Carolina, Chapel HillCo-taught with Dr. Thomas Rice

BIBLIOGRAPHY:

Book Chapters:

1. Williams PL. Sample size calculations for failure time data. In (Finkelstein, D.M. andSchoenfeld, D.A., eds.), AIDS Clinical Trials. 1995; New York: Wiley.

2. Williams PL and Ryan LM. Dose-response models for developmental toxicity. In (Hood,R.D., ed.) Handbook of Developmental Toxicology, 1997; Boca Raton: CRC Press, Inc., p.635-666.

3. Williams PL. Trend tests for counts and proportions. In (Armitage, P. and Colton, T., eds)Encyclopedia of Biostatistics, Section 10: Categorical Data Analysis. 2005; Wiley. DOI:10.1002/0470011815.b2a10060.

4. Williams PL. Reproductive toxicology. (El-Shaarawi AH and Piegorsch W,eds) Encyclopediaof Environmetrics. 2001; Wiley: New York. DOI: 10.1002/9780470057339.var037

5. Williams PL. Quantitative Structure-Activity Relationships (QSAR). (El-Shaarawi AH andPiegorsch W,eds) Encyclopedia of Environmetrics. 2001; Wiley: New York. DOI: 10.1002/9780470057339.vaq003

6. Williams PL and Geys H. Individual Level Covariates. In, (Aerts M, Geys H, Molenberghs,and Ryan, ed) Topics in Modelling of Clustered Data 2002; Boca Raton: Chapman andHall/CRC Press, p. 207-232.

7. Williams PL. Statistical Methods for Toxicology. In Encyclopedia of Life Support Sys-tems 2004; Developed under the Auspices of the UNESCO, Eolss Publishers, Oxford, UK,[http://www.eolss.net]

Peer-reviewed Publications:

1. Williams PL and Portier CJ. Explicit solutions for constrained MLE’s in survival/sacrificeexperiments. Biometrika 1992; 79(4):717-29.

2. Williams PL and Portier CJ. Analytic expressions for maximum likelihood estimators in anonparametric model of tumor incidence and death. Communications in Statistics 1992;21(3): 711-32.

3. Scharfstein DO and Williams PL. Design of developmental toxicity studies for assessing jointeffects of dose and duration. Risk Analysis 1994; 14:1057-71.

4. Hoppin JA, Aro ACA, Williams PL, Hu H, Ryan PB. Validation of K-XRF bone leadmeasurement in adolescents. Environmental Health Perspectives 1994; 103:78-103.

5. Weller EA, Catalano PJ, and Williams PL. Implications of developmental toxicity studydesign for quantitative risk assessment. Risk Analysis 1995; 15:567-574.

6. Finkelstein DM, Williams PL, Molenberghs G, Feinberg J, Powderly WG, Kahn J, Dolin Rand Cotton DJ. Patterns of opportunistic infections in patients with HIV Infection, Journalof AIDS and Human Retrovirology 1996; 12:38-45.

7. Williams PL, Molenberghs G, and Lipsitz SR. Analysis of multiple ordinal outcomes indevelopmental toxicity studies. Journal of Agricultural, Biological, and EnvironmentalStatistics 1996 1(2):1-25.

8. Williams PL. Discussion of “Extending the Dewanji and Kalbfleisch Model to IncorporateMarker Data” by McMillan, A. and Silvers, A. Environmental and Ecological Statistics1996.

9. Williams PL. Sequential monitoring of clinical trials with multiple survival endpoints. Statis-tics in Medicine 1996; 15:2341-2357.

10. Williams PL, and Ryan LM. Design of multiple binary outcome studies with intentionallymissing data. Biometrics 1996; 52:1498-1514.

11. Williams PL. Using descriptive statistics in clinical trials. Research Nurse 1997; 3(3).

12. MacIntosh DL, Williams PL, Hunter DJ, Morris SC, Willett WC, and Rimm EB. Evaluationof a food frequency questionnaire-food composition approach for estimating dietary intakeof inorganic arsenic and methylmercury. Cancer Epidemiology, Biomarkers, and Prevention1997; 6:1043-1050

13. Parenti DM, Williams PL, Hafner R, Jacobs MR, Hojczyk P, Limjoco M, Ellner JJ, andthe ACTG 135 Study Team. A Phase II/III trial of rifampin, ciprofloxacin, clofazamine,ethambutol, with or without amikacin in the treatment of disseminated mycobacteriumavium infection in HIV-infected individuals. AIDS 1998; 12:2439-2446.

14. Rimm EB, Williams PL, Fosher K, Criqui M, and Stampfer MJ. Moderate alcohol intakeand lower risk of coronary heart disease: meta-analysis of effects on lipids and hemostaticfactors. British Medical Journal 1999; 319:1523-1528.

15. Williams PL, Currier JS, Swindells S. Joint effects of HIV-1 RNA levels and CD4 lymphocytecount on the risk of specific opportunistic infections. AIDS 1999; 13:1035-1044.

16. Weller E, Long N, Smith A, Williams P, Ravi S, Gill J, Skornik W, Brain J, Kimmel C, Kim-mel G, Holmes L, Ryan L. Dose-rate effects of ethylene oxide exposure on developmentaltoxicity. Toxicological Sciences 1999; 50:259-270.

17. Benson CA, Williams PL, Cohn DL, Becker S, Hojczyk P, Nevin T, Korvick J, Heifets L,Child CC, Lederman M, Reichman RC, Powderly WG, Notario GF, Wynne BA, Hafner R,and the ACTG 196/CPCRA 009 Protocol Team. Clarithromycin or rifabutin alone or incombination for primary prophylaxis of mycobacterium avium complex disease in patientswith AIDS: A randomized, double-blind, placebo-controlled trial. Journal of InfectiousDisease 2000; 181:1289-1297.

18. USPHS/IDSA Prevention of Opportunistic Infections Working Group. 1999 USPHS/IDSAGuidelines for the prevention of opportunistic infections in persons infected with humanimmunodeficiency virus. Clinical Infectious Diseases 2000; 30, Supplement 1:29-65.

19. Currier JS, Williams PL, Koletar SL, Cohn SE, Murphy RL, Heald AE, Hafner R, Bassily E,Lederman HM, Knirsch C, Benson CA, Lederman MM, Aberg JA, McCutchan JA, for theACTG 362 Study Team. Discontinuation of MAC prophylaxis for subjects with antiretro-viral therapy induced CD4 increases: A randomized, double-blind, placebo-controlled trial.Annals of Internal Medicine 2000; 133:493-503.

20. Hoppin JA, Williams PL, and Ryan PB. A conceptual framework for the interpretationof biological markers for environmental exposure assessment. Human and Ecological RiskAssessment 2000; 6:711-725

21. Betensky RA Williams PL, and Lederman HL. A comparison of models for clustered binaryoutcomes: analysis of a designed immunology experiment. Applied Statistics 2001; 50:43-61.

22. French J and Williams PL. Characterizing dose-response relationships in multiple cancerbioassays. Risk Analysis 2001; 21:91-102.

23. Currier JS, Williams PL, Feinberg J, Becker S, Owens S, Fichtenbaum C, and Benson C forthe AIDS Clinical Trials Group. Impact of prophylaxis for Mycobacterium avium complex(MAC) on bacterial infections in advanced HIV disease. Clinical Infectious Diseases 2001;32:1615-22.

24. Evans JS, Rhomberg L, Williams PL, Wilson A, and Baird SJ. Reproductive and develop-mental risks from ethylene oxide: A probabilistic characterization of possible regulatorythresholds. Risk Analysis 2001; 21:697-717.

25. von Reyn CF, Williams PL, Currier JS, Lederman HM, McCutchan JA, Koletar SL, MurphyRL, Cohn SE, Evans T, Heald AE, Colquhoun D. and the ACTG 899 Protocol Team. Skintest reactivity to Mycobacterium avium sensitin in AIDS patients at risk for disseminatedM. Avium infection. Clinical and Diagnostic Laboratory Immunology 2001; 8:1277-1278.

26. Magari SR, Hauser R, Schwartz J, Williams PL, Smith TJ, and Christiani DC. Associationof heart rate variability with occupational and environmental exposure to particulates.Circulation 2002; 104:986-991.

27. Geys H, Molenberghs G, and Williams PL. Analysis of toxicology data with covariates spe-cific to each observation. Journal of Agricultural, Biological, and Environmental Statistics2002; 7(2):1-15.

28. Molenberghs G, Williams PL, and Lipsitz SR. Prediction of survival and opportunisticinfections in HIV infected patients: a comparison of imputation methods of incompleteCD4 counts. Statistics in Medicine 2002; 21:1387-1408.

29. Magari SR, Schwartz J, Williams PL, Hauser R, Smith TJ, and Christiani DC. The associ-ation between personal measurements of environmental exposure to particulates and heartrate variability. Epidemiology 2002; 13:305-310.

30. Cohn SE, Kammann E, Williams P, Currier JS, and Chesney MA. Association of adher-ence to mycobacterium avium complex prophylaxis and antiretroviral therapy with clinicaloutcomes in Acquired Immunodeficiency Syndrome. Clinical Infectious Diseases 2002; 34(8):1129-36.

31. Magari SR, Schwartz J, Williams PL, Hauser R, Smith TJ, and Christiani DC. The asso-ciation of particulate air metal concentrations with heart rate variability. EnvironmentalHealth Perspectives 2002; 110:875-880.

32. Kimmel GL, Williams PL, Kimmel CA, Claggett TW, and Tudor N Response-surface anal-ysis of exposure-duration relationships: the effects of hyperthermia on embryonic develop-ment of the rat in vitro. Toxicological Sciences 2002; 69:391-399.

33. Lee MM, Sergeyev O, Williams P, Korrick S, Zeilert V, Revich B, and Hauser R. Phys-ical growth and sexual maturation of boys in Chapaevsk, Russia. Journal of PediatricEndocrinology and Metabolism 2003; 16:169-178.

34. Kavlock R, Boekelheide K, Chapin R, Cunningham M, Faustman E, Foster P, Golub M,Henderson R, Hinberg I, Little R, Seed J, Shea K, Tabacova S, Tyl R, Williams P,Zacharewski Z. NTP Center for the Evaluation of Risks to Human Reproduction: phtha-lates expert panel report on the reproductive and developmental toxicity of butyl benzylphthalate (453-487), di-n-butyl phthalate (489-527), di(2-ethylhexyl) phthalate (529-653),di-isodecyl phthalate (655-678), di-isononyl phthalate (679-708), di-n-hexyl phthalate (709-720), and di-n-octyl phthalate (721-734). Reproductive Toxicology 2002; 15.

35. Aberg JA, Williams PL, Liu T, Lederman HM Hafner R, Torriani FJ, Lennox JL, DubeMP, MacGregor RR, Currier JS and the ACTG 393 Study Team. A study of discontin-uing maintenance therapy in subjects with disseminated Mycobacterium avium complex(DMAC): ACTG 393. Journal of Infectious Diseases 2003; 187:1046-1052.

36. Benson CA, Williams PL, Currier JS, Holland F, Mahon LF, MacGregor RR, InderliedCB, Flexner C, Neidig J, Chaisson R, Notario GF, Hafner R, and the ACTG 223 ProtocolTeam. A prospective, randomized trial comparing the efficacy and safety of clarithromycinin combination with either ethambutol, rifabutin or both for the treatment of disseminatedmycobacterium avium complex (MAC) disease in persons with AIDS. Clinical InfectiousDiseases 2003; 37:1234-43.

37. Lederman HM, Williams PL, Wu JW, Evans TG, Cohn SE, McCutchan JA, Koletar SL,Hafner R, Connick E, Valentine FT, McElrath MJ, Roberts NJ, and Currier JS for the AIDSClinical Trials Group 889 Study Team. Incomplete immunologic reconstitution followinginstitution of highly active antiretroviral therapy (HAART) in HIV-infected patients withsevere CD4 depletion. Journal of Infectious Diseases 2003; 188:1794-1803.

38. Seeger JD, Walker AM, Williams PL, Saperia GM, Sacks FM. A propensity score-matchedcohort study of the effect of statins, mainly fluvastatin, on the occurrence of acute myocar-dial infarction. Am J Cardiol 2003; 92:1447-1451.

39. Mucci LA, Hsieh CC, Williams PL, Dickman PW, Bjorkman L, Pedersen N. Birth order,sibship size, and housing density in relation to tooth loss and periodontal disease: a cohortstudy among Swedish twins. American Journal of Epidemiology 2004; 159: 499-506.

40. Pitiphat W, Crohin C, Williams P, Merchant AT, Douglass CW, Colditz GA, and JoshipuraKJ. Use of pre-existing radiographs for assessing periodontal disease in epidemiologic stud-ies. Journal of Public Health Dentistry 2004; 64:223-30.

41. Koletar SL, Williams PL, Wu J, McCutchan JA, Cohn SE, Murphy RL, Lederman HM andCurrier JS for the ACTG 362 Study Team. Long-term follow-up of HIV-infected individualswho have significant CD4 increases with antiretroviral therapy. Clinical Infectious Diseases2004; 39:1500-6.

42. Hauser R, Williams P, Altshul L, Korrick S, Peeples L, Patterson D, Turner WE, Lee MM,Revich B, Zeilert V, Sergeyev 0. Predictors of serum dioxin levels among adolescent boysin Chapaevsk, Russia. Organohalogen Compounds 2004; 66:3245-51.

43. Mrus J, Williams PL, Tsevat J, Cohn SE, and Wu A. Gender differences in reported health-related quality of life in patients with HIV/AIDS. Quality of Life Research 2005; 14:479-91.

44. Meyer KA, Williams P, Hernandez-Diaz S, Cnattinguius S. Smoking and the risk of oralclefts: exploring the impact of study designs. Epidemiology 2004; 15(6):671-8.

45. Hines RN, Adams J, Buck GM, Faber W, Holson JF, Jacobson SW, Keszler M, McMartin K,Segraves RT, Singer LT, Sipes IG, Williams PL. NTP-CERHR Expert Panel report onthe reproductive and developmental toxicity of fluoxetine. Birth Defects Research B, DevReprod Toxicol 2004; 71(4):193-280.

46. Liu Y, Woodin MA, Hauser R, Williams PL, Herrick RF, Christiani DC, Smith TJ. Es-timation of personal exposures to particulate matter and metals in boiler overhaul work.Journal of Occupational and Environmental Medicine 2005; 47:68-78.

47. Seeger JD, Williams PL, Walker A. An application of propensity score matching using claimsdata. Pharmacology and Drug Safety 2005; 14:465-476.

48. Hauser R, Williams P, Altshul L, Calafat A. Evidence of interaction between polychlorinatedbiphenyls and phthalates in relation to human sperm motility. Environmental Health Per-spectives 2005; 113(4):425-430.

49. Brogly S, Williams P, Seage G, Oleske J, Van Dyke R, and MacIntosh K for the PACTG219C Team. Antiretroviral treatment use in pediatric HIV in the United States: fromclinical trials to clinical practice. JAMA 2005; 293(18):2213-2220.

50. Thurston SW, Williams PL, Hauser R, and Spiegelman D. A comparison of regression cali-bration methods for studies with internal validation data. Journal of Statistical Planningand Inference 2005; 131(1):175-190.

51. Gong MN, Thompson BT, Williams P, Pothier L, Boyce PD, Christiani DC. Clinical Pre-dictors of ARDS and Mortality in ARDS: Potential Role of Red Cell Transfusion. CriticalCare Medicine 2005; 33(6):1191-8.

52. Gong MN, Zhou Z, Williams P, Thompson BT, Pothier L, Boyce PD, Christiani DC. 308GAand TNFB polymorphisms in acute respiratory distress syndrome. European RespiratoryJournal 2005; 26:382-9.

53. Pitiphat W, Gillman MW, Joshipura KJ, Williams PL, Douglass CW, Rich-Edwards JW.Plasma C-Reactive protein in early pregnancy and preterm delivery. Am J Epidemiol 2005;162:1108-13. PMCID: PMC1994922.

54. Hauser R, Williams P, Altshul L, Korrick S, Peeples L, Patterson D, Turner W, Lee M, Re-vich B, Sergeyev O. Predictors of serum dioxin levels among adolescent boys in Chapaevsk,Russia: A cross-sectional study. Environmental Health 2005; 4(8): doi:10,1186.1476-069X-4-8.

55. Koletar SL, Williams PL, Wu J, McCutchan JA, Cohn SE, Murphy RL, Lederman HM,Currier JS for the ACTG 362 Study Team. Reply to “How infrequent are opportunisticdisease and immune reconstitution syndromes among HIV-infected individuals who havefavorable CD4+ cell count response to antiretroviral therapy?” by Phillips. Clin Infect Dis2005; 40(9):1380-1381.

56. Liu Y, Woodin MA, Smith TJ, Herrrick RF, Williams PL, Hauser R, Christiani DC. Ex-posure to fuel-oil ash and welding emissions during the overhaul of an oil-fired boiler. JOccup Environ Hyg 2005; 2(9):435-43.

57. Gong MG, Thompson BT, Williams PL, Wei Z, Zhaoxi M, Pothier L, and Christiani DC.Interleukin-10 polymorphism in position -1082 and acute respiratory distress syndrome.European Respiratory Journal 2006; 27:674-81. PMCID: PMC3090261.

58. Brogly S, Williams PL, Seage GR, Van Dyke RB. In utero nucleoside reverse transcriptaseexposure and cancer in HIV-uninfected children: an update from the Pediatric AIDS Clin-ical Trials Group 219 & 219C cohorts. Journal of Acquired Immune Deficiency Syndrome2006; 41:535-536.

59. Pitiphat W, Joshipura KJ, Rich-Edwards JW, Williams PL, Douglass C, and Gillman MW.Periodontitis and plasma C-reactive protein during pregnancy. Journal of Periodontology2006; 77(5):821-825. PMCID: PMC1994911.

60. Gona P, Van Dyke RB, Williams PL, Dankner WM, Chernoff M, Nachman SA, and SeageGR. Incidence of opportunistic and other infections in HIV-Infected children in the HAARTera. JAMA 2006; 296:292-300.

61. Williams PL, Storm D, Montepiedra G, Nichols S, Kammerer B, Sirois P, Farley J, andMalee K for the PACTG 219C Team. Predictors of adherence to antiretroviral medicationsin children and adolescents with HIV infections. Pediatrics 2006; 118:e1745-57.

62. Kavlock R, Barr D, Boekelheide K, Breslin W, Breysse P, Chapin R, Gaido K, Hodgson E,Marcus M, Shea K, and Williams P. NTP-CERHR expert panel update on the repro-ductive and developmental toxicity of di(2-ethylhexyl) phthalate. Reproductive Toxicology2006; 22:291-399.

63. Gong MN, Zhou W, Williams PL, Thompson BT, Pothier L, and Christiani DC. Polymor-phisms in the Mannose Binding Lectin-2 Gene and Acute Respiratory Distress Syndrome.Critical Care Medicine 2007; 35:48-56. PMCID: PMC3090269.

64. Badovinac R, Werler M, Williams P, Kelsey K, and Hayes C. Folic acid-containing sup-plement consumption during pregnancy and risk for oral clefts: A meta-analysis. BirthDefects Research (Part A) 2007; 79(1):8-15.

65. McCutchan JA, Wu J, Roberson K, Koletar S, Ellis R, Taylor M, Woods S, Heaton R, Currier Jand Williams P for the ACTG 362 Team. HIV suppression by HAART preserves cognitivefunction in advanced, immune-reconstituted AIDS patients. AIDS 2007; 21:1109-1117.

66. McCarty KM, Ryan L, Houseman EA, Williams PL, Miller DP, Quamruzzaman Q, RahmanM, Mahiuddin G, Smith T, Gonzalez E, Su L, Christiani DC. A case-control study of GSTpolymorphisms and arsenic related skin lesions. Environmental Health 2007; 6(5). PMCID:PMC1805433.

67. Hughes MD and Williams PL. Challenges in using observational studies to evaluate adverseeffects of treatment. N Engl J Med 2007; 356(17):1705-7.

68. Pitiphat W, Joshipura KJ, Gillman MW, Williams PL, Douglass C, and Rich-Edwards JW.Maternal periodontitis and adverse pregnancy outcomes. Community Dentistry and OralEpidemiology 2008; 36(1):3-11.

69. Lyon M, Williams PL, Woods E, Butler A, Sibinga E, Brady M, and Oleske J for thePACTG 219C Team. Do Not resuscitate orders and/or hospice care, psychological healthand quality of life among children/adolescents with Acquired Immune Deficiency Syndrome.Journal of Palliative Care 2008; 11:459-69. PMCID: PMC2782484.

70. Patel K, Hernan M, Williams P, Seeger J, McIntosh K, Van Dyke R, and Seage III GR forthe PACTG 219/219C Study Team. Long term effectiveness of highly active antiretroviraltherapy (HAART) on the survival of children and adolescents infected with HIV-1. ClinInfect Dis 2008; 46(4):507-15.

71. Tassiopoulous K, Williams PL, Seage G, Crian M, Oleske J, and Farley J. Association ofhypercholesterolemia incidence with antiretroviral treatment including protease inhibitorsamong perinatally HIV-infected children. Journ Acquir Immune Defic Syndr 2008: 47(5):607-14. PMCID: PMC3089963.

72. Adibi JJ, Whyatt RM, Williams PL, Calafat AM, Camann D, Herrick R, Nelson H, Bhat HK,Perera FP, Silva MJ, and Hauser R. Characterization of phthalate exposure among pregnantwomen assessed by repeat air and urine samples. Environmental Health Perspectives 2008;116(4):467-473. PMCID: PMC2291011.

73. Patel K, Hernan MA, Williams PL, Seeger JD, McIntosh K, VanDyke RB, and Seage GR III.Long-term effects of highly active antiretroviral therapy on CD4 evolution among childrenand adolescents infected with HIV-1: Five years and counting. Clinical Infectious Diseases2008; 46:1651-60. PMCID: PMC3154876.

74. Williams PL, Van Dyke R, Eagle M, Smith D, Vincent C, Cuipak G, Oleske J, and SeageGR III for the PACTG 219C Team. Association of site-specific and participant-specificfactors with retention of children in a long-term pediatric HIV cohort study. AmericanJournal of Epidemiology 2008; 167:1375-86. PMCID: PMC2862644.

75. Nachman S, Chernoff M, Williams PL, Gona P, Van Dyke R, Dankner W, and Seage G.Incidence of non-infectious complications in perinatally HIV-infected children and adoles-cents in the HAART era. Arch Pediatr Adolesc Med, 2009; 163(2):164-171. PMCID:PMC2730663.

76. Hauser R, Sergeyev O, Korrick S, Lee MM, Revich B, Gitin E, Burns J, and Williams P.Association of blood lead levels with onset of puberty in Russian boys. EnvironmentalHealth Perspectives 2008; 116(7):976-980. PMCID: PMC2453170.

77. Van Dyke R, Wang L, Williams PL. Toxicity of combination NRTI regimens in treatmentof pediatric HIV infection. Journal of Infectious Diseases 2008; 198:1599-1608. PMCID:PMC2737265.

78. Malee K, Williams PL, Montepiedra G, Nichols S, Sirois PA, Storm D, Farley J, KammererB and the PACTG 219C Team. The role of cognitive functioning in medication adherencein children and adolescents with HIV infection. Journal of Pediatric Psychology 2009;34(2):165-75. PMCID: PMC2722123.

79. Butler A, Williams P, Howland L, Hutton A, Storm D, and Seage GR III. Disclosure of HIVinfection status and health-related quality of life in children with HIV infection. Pediatrics2009; 123:935-943. PMCID: PMC2697844.

80. Williams PL, Wu J, Cohn SE, Koletar SL, McCutchan JA, Murphy RL, and Currier JSfor the ACTG 362 Study Team. Improvement in lipid profiles over 6 years of follow-up inadults with AIDS and immune reconstitution. HIV Medicine 2009; 10:290-301. PMCID:PMC2778216.

81. Andiman W, Chernoff M, Mitchell C, Oleske J, Williams P, Kaiser K, Pirswani M, SpiegelH, Seage III GR, and iDACS 617 Study Group. Incidence of renal laboratory abnormalitiesamong children enrolled in PACTG 219/219C and the association with race, ethnicity, age,

and the use of pharmacological agents (including antiretrovirals). Pediatr Infect Dis J2009; 28:619-625. PMCID: PMC3192653.

82. Levin M, Anderson J, Seage G, and Williams PL. Herpes zoster in HIV-infected children be-fore and after the availability of highly active antiretroviral therapy. Journ Acquir ImmuneDefic Syndr 2009; 50:182-191. PMCID: PMC2748317.

83. Adibi JJ, Hauser R, Williams PL, Whyatt RM, Calafat AM, Nelson H, Herrick R, and SwannSH. Maternal urinary metabolites of di-(2-ethylhexyl) phthalate in relation to the timingof labor in a US multi-center pregnancy cohort. Am J Epidemiol 2009; 169(8):1015-24.PMCID: PMC2727228.

84. Chernoff M, Nachman S, Williams P, Brouwers P, Heston J, Hodge J, DiPoalo V, DeygooNS, Gadow K and the IMPAACT P1055 Study Team. Mental health interventions in HIV-Infected and uninfected children and adolescents enrolled in PACTG P1055. Pediatrics2009; 124:627-36. PMCID: PMC2764487.

85. Patel K, Ming X, Williams PL, Robertson KR, Oleske JM, and Seage GR for the In-ternational Maternal Pediatric Adolescent AIDS Clinical Trials 219/219C Study Team.Impact of HAART and CNS-penetrating antiretroviral regimens on HIV-encephalopathyamong perinatally-infected children and adolescents. AIDS 2009; 23:1893-1901. PMCID:PMC2821205.

86. Adibi JJ, Hauser R, Williams PL, Whyatt RM, Thaker HM, Nelson H, Herrick R, andBhat HK. Placental biomarkers of phthalate effects on mRNA transcription: application inepidemiologic research. Environmental Health 2009; 8(20). doi:10.1186/1476-069X-8-20.PMCID: PMC2678110.

87. Burns JS, Williams PL, Sergeyev O, Korrick S, Lee MM, Revich B, Altshul L, Patterson JrDG, Turner WE, Saharov I, and Hauser R. Predictors of serum dioxins and PCBs amongperi-pubertal Russian boys. Environmental Health Perspectives 2009; 117(10):1593-1599.PMCID: PMC2790515.

88. Mucci L, Hsieh CC, Williams PL, Arora M, Adami H-O, de Faire U, Douglass CW, andPederson NL. Do genetic factors explain the association between poor oral health andcardiovascular factors? A prospective cohort study among Swedish twins. Am J Epidemiol2009; 170(5):615-21. PMCID: PMC2732998.

89. Brady MT, Oleske J, Williams PL, Elgie C, Mofenson LM, Dankner WM, and Van Dyke Rfor the PACTG 219/219c Team. Declines in mortality rates and changes in causes of deathin HIV-1 infected children during the HAART era. Journ Acquir Immune Defic Syndr2010; 53(1):86-94. PMCID: PMC2801894.

90. Williams PL, Marino M, Malee K, Brogly S, Hughes MD, and Mofenson L for the PACTG219C Team. Neurodevelopmental and in utero antiretroviral exposure of HIV-exposeduninfected infants. Pediatrics 2010; 125(2):e250-260. PMCID: PMC2951128.

91. Sirois PA, Montepiedra G, Kapetanovic S, Williams PL, Pearson DA, Malee K, Garvie PA,Kammerer BL, Nichols SL, Nozyce ML, Mintz M, Mitchell WG, and Oleske JM for theIMPAACT/PACTG 219C Team. Impact of medications commonly prescribed for treat-ment of attention and behavior disorders on physical growth. J Dev Behav Pediatr 2009;30(5):403-412. PMCID: PMC2836888.

92. Kapetanovic S, Aaron L, Montepiedra G, Sirois P, Oleske J, Malee K, Pearson D, Nichols S,Garvie P, Farley J, Nozyce M, Mintz M, and Williams PL for the IMPAACT/PACTG219C Team. The use of second generation antipsychotics and the changes in physicalgrowth in children and adolescents with perinatally acquired HIV. AIDS Patient Care andSTDs 2009; 23(11):939-47. PMCID: PMC2832650.

93. Serchuck L, Williams PL, Nachman S, Gadow KD, Chernoff M, and Schwartz L for theIMPAACT 1055 Team. Prevalence of pain and association with psychiatric symptomseverity in perinatally HIV-infected and HIV-uninfected children and adolescents. AIDSCare 2010; 22(5):640-648. PMCID: PMC3156589.

94. Mok-Lin E, Ehrlich S, Williams PL, Petrozza J, Wright D, Calafat AM, Ye X, and Huaser R.Urinary bisphenol A concentrations and ovarian response among women undergoing IVF.International Journal of Andrology 2010; 33(2):385-93. PMCID: PMC3089904.

95. Siberry GK, Williams PL, Lujan-Zilberman J, Warshaw MG, Spector SA, Decker MD,Heckman BE, Demske EF, Read JS, Jean-Philippe P, Kabat W, and Nachman S for theIMPAACT P1065 Protocol Team. Phase I/II open label trial of safety and immunogenicityof meningococcal (Groups A, C, Y, and W-135) polysaccharide diptheria Toxoid conjugatevaccine (MCV-4) in Human immunodeficiency virus-infected adolescents. Pediatr InfectDis J 2010; 29(5):391-396. PMCID: PMC2868314.

96. Adibi JJ, Whyatt RM, Hauser R, Bhat HK, Davis BJ, Calafat AM, Hoepner LA, Perera FP,Tang D, and Williams PL. Transcriptional biomarkers of steroidogenesis and trophoblastdifferentiation in the placenta in relation to prenatal phthalate exposure. EnvironmentalHealth Perspectives 2010; 118(2):291-6. PMCID: PMC2831932.

97. Gadow K, Chernoff M, Williams P, Brouwers P, Morse E, Heston J, Hodge J, DiPoalo V,Deygoo NS, Nachman S and the PACTG P1055 Study Team. Co-occuring psychiatricsymptoms in children perinatally-infected with HIV and peer comparison sample. J DevBehav Pediatr 2010; 31(2):116-128. PMCID: PMC2868331.

98. Williams PL, Sergeyev O, Lee MM, Korrick S, Burns JS, O, DelPrato J, Revich B, andHauser R. Blood lead levels and delayed onset of puberty in a longitudinal study of Russianboys. Pediatrics 2010; 125(5):e1088-96. PMCID: PMC3111933.

99. Brogly S, Abzug M, Watts DH, Cunningham C, Williams PL, Oleske J, Conway D, Sper-ling R, Spiegel H, and Van Dyke RB. Birth defects among children born to HIV-infected[pregnant women: Pediatric AIDS Clinical Trials protocols 219 and 219C. Pediatr InfectDis J 2010; 29(8):721-7. PMCID: PMC2948952.

100. Kapetanovic S, Leister E, Nichols S, Miller T, Tassiopoulos K, Hazra R, Gelbard HA, MaleeK, Kammerer B, Mendez A, and Williams PL for the Pediatric HIV/AIDS Cohort Team.Relationships between biomarkers of vascular dysfunction with neurodevelopment outcomesin perinatally HIV-infected children. AIDS 2010; 24(10):1481-91. PMCID: PMC2885052.

101. Humblet O, Williams PL, Korrick SA, Sergeyev O, Emond C, Birnbaum LS, Burns JS,Altshul L, Patterson DG, Turner WE, Lee MM, Revich B, and Hauser R. Predictors ofserum dioxin, furan and PCB concentrations among women from Chapaevsk, Russia. EnvScience and Technology 2010; 44(14):5633-5640. PMCID: PMC3128795.

102. Kapetanovic S, Aaron L, Williams PL, Farley J, Sirois PA, Garvie PA, Pearson DA, OleskeJM, and Montepiedra G for the IMPAACT/PACTG 219C Study Team. Relationshipsbetween the use of second-generation antipsychotics and changes in total cholesterol levelsin children and adolescents perinatally infected with HIV. Neurobehavioral HIV Medicine2010; 2:39-48. PMCID: PMC2943434.

103. Williams PL, Leister E, Chernoff M, Nachman S, Morse E, and Gadow KD for the IMPAACTP1055 Team. Substance use and its association with psychiatric symptoms in perinatallyHIV-infected and uninfected adolescents. AIDS and Behavior 2010; 14(5):1072-82. PM-CID: PMC2949058.

104. Cohn SE, Jiang HJ, McCutchan JA, Koletar SL, Murphy RL, Robertson KR, deSt MauriceA, Currier JS and Williams PL. Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: Results from ACTG362. AIDS Care 2011; 23(6):775-85. PMCID: PMC3095689.

105. Li S, Williams PL, and Douglass CW. Development of a clinical guideline to predict undiag-nosed diabetes in dental patients. J Am Dent Assoc 2011; 142(1):28-37. PMID: 21193764.

106. Burns JS, Williams PL, Sergeyev O, Korrick S, Lee MM, Revich B, Altshul L, DelPrato JT,Humblet O, Patterson Jr DG, Turner WE, Needham LL, Starovoytov M, and Hauser R.Serum dioxins and polychlorinated biphenyls are associated with growth among Russianboys. Pediatrics 2011; 127(1):e59-86. PMCID:PMC3010086

107. Brogly SB, DiMauro S, Van Dyke RB, Williams PL, Naini A, Libutti DE, Choi J, Chung M,Gerschenson M. Transplacental nucleoside analogue exposure and mitochondrial parame-ters in HIV-uninfected children. AIDS Research and Human Retroviruses 2011; 27(7):777-83. PMCID: PMC3159117.

108. Malee K, Williams PL, Montepiedra G, Nichols S, Sirois PA, Storm D, Farley J, KammererB and the PACTG 219C Team. Medication adherence in children and adolescents withHIV infection: Associations with behavioral impairment. AIDS Patient Care and STDs2011; 25(3):191-200. PMCID: PMC3101948.

109. Meeker JD, Maity A, Missmer SA, Williams PL, Mahalangaiah S, Ehrlich S, Perry MJ,Cramer DW and Hauser R. Serum concentrations of polychlorinated biphenyls (PCBs) in

relation to in vitro fertilization (IVF) outcomes. Environmental Health Perspectives 2011;119(7):1010-6. PMCID: PMC3222973.

110. Malee KM, Tassiopoulos K, Huo Y, Siberry GK, Williams PL, Hazra R, Smith RA, AllisonSM, Garvie P, Kammerer B, Kapetanovic S, Nichols S, Van Dyke R, Seage III GR andMellins CM for the Pediatric HIV/AIDS Cohort Study Team. Mental health functioningamong children and adolescents with perinatal HIV infection or exposure. AIDS Care 2011;23(12):1533-44. PMCID: PMC3062576.

111. Korrick SK, Lee MM, Williams PL, Sergeyev O, Burns JS, Patterson DG, Turner WE,Needham LL, Altshul L, Revich B, and Hauser R. Dioxin exposure and age of pubertal onsetamong Russian boys. Env Health Perspect 2011; 119(9):1339-44. PMCID: PMC3230396.

112. Jacobson D, Williams PL, Tassiopoulos K, Melvin A, Hazra R, and Farley J for the IM-PAACT 219/219C Study Team. Clinical management and follow-up of hypercholesterolemiaamong perinatally HIV-infected children enrolled in the PACTG 219C Study. Journ AcquirImmune Defic Syndr 2011; 57(5):413-20. PMCID: PMC3159838.

113. Griner R, Williams PL, Read JS, Seage III GR, Crain M, Yogev R, Hazra R, Rich K forthe Pediatric HIV/AIDS Cohort Study. In Utero and postnatal exposure to antiretroviralsamong HIV-exposed but uninfected children in the United States. AIDS Patient Care andSTDs 2011; 25(7):385-94. PMCID: PMC3125552.

114. Kim FM, Hayes C, Williams PL, Whitford GM, Joshipura K, Hoover RN, Douglass CW,Simon M, Gebhardt M, Scarborough M, Gitelis S, Eckardt J, Neff J, Joyce M, MalawerM, McGuire M, Andersen H. An assessment of bone fluoride and osteosarcoma. Journalof Dental Research 2011; 90(10):1171-6. PMCID: PMC3173011.

115. Humblet O, Sergeyev O, Althshul L, Korrick SA, Williams PL, Emond C, Birnbaum LS,Burns JS, Lee MM, Revich B, Shelepchikov A, Feshin D, and Hauser R. Temporal trendsin serum concentrations of polychlorinated dioxins, furans, and PCBs among adult womenliving in Chapaevsk, Russia: a longitudinal study from 2000 to 2009. Environmental Health2011; 10:62. PMCID: PMC3142486.

116. Crain MJ, Williams PL, Griner R, Tassiopoulos K, Read JS, Mofenson LM, and Rich KD,for the Pediatric HIV/AIDS Cohort Study. Association of capillary blood lactate and inutero exposure to HIV and antiretrovirals. Pediatr Infect Dis J 2011; 30(12):1069-74.PMCID: PMC3242409.

117. Humblet O, Williams PL, Korrick S, Sergeyev O, Emond C, Birnbaum LS, Burns JS, AltshulL, Patterson Jr DG, Turner WE, Lee MM, Revich B, and Hauser R. Dioxins and polychlo-rinated biphenyls in mother’s serum and the timing of pubertal onset in sons.Epidemiology2011; 22(6):827-35. PMCID: PMC3741104.

118. Siberry G, Warshaw M, Williams P, Spector SA, Decker MD, Jean-Phillipe P, Yogev R,Heckman BE, Manzella A, Roa J, Nachman S, Lujan-Zilbermann J for the IMPAACTP1065 Team. Safety and immunogenicity of quadrivalent meningococcal conjugate vaccinein 2- to 10-year-old human immunodeficiency virus-infected children. Pediatr Infect Dis J2012; 31(1):47-52. PMCID: PMC3252429.

119. Mahalingaiah S, Missmer SA, Maity A, Williams PL, Meeker J, Berry K, Ehrlich S, PerryMJ, Kramer DW, and Hauser R. Association of hexachlorobenzene (HCB), dichlorodiphenyl-trichloroethane (DDT) and dichlorodiphenyldichloroethane (DDE) with in vitro fertiliza-tion (IVF) outcomes. Environmental Health Perspectives 2011; 120(2):316-320. PMCID:PMC3279437.

120. Rice MK, Buchanan AL, Siberry GK, Malee KM, Frederick T, Purswani MU, Hoffman HJ,Sirois P, Smith R, Torre P, Allison SM, and Williams PL for the Pediatric HIV/AIDSCOhort Study (PHACS). Language impairment in perinatally HIV-infected children andHIV-exposed uninfected children. J Dev Behav Pediatr 2011; 33(2):112-123. PMCID:PMC3310927.

121. Burns JS, Williams PL, Sergeyev O, Korrick S, Lee MM, Revich B, Altshul L, Del Prato JT,Humblet O, Patterson DG, Turner WE, Starovoytov M, Hauser R. Serum concentrations oforganochlorine pesticides and growth among Russian boys. Environ Health Perspect 2011;120(2):303-308. PMCID: PMC3279441.

122. Triant VA, Josephson F, Rochester G, Althoff K, Marcus K, Munk B, Cooper C, D’AgostinoRB, Costagliola D, Sabin C, Williams PL, Hughes S, Post W, Chandra-Strobos N,Guaraldi G, Young S, Obenchain R, Bedimo R, Miller V, and Strobos J. Adverse outcomeanalyses of observational data: interpretation for clinical decision-making. Clin Infect Dis2012; 54(3):408-413. PMCID: PMC3258276.

123. Weinberg A, Huang S, Song LY, Fenton T, Williams P, Patterson J, Tova-Salazar A, andLevin M. Immune correlates of herpes zoster in HIV-infected children and youth. Journalof Virology 2012; 86(5):2878-81. PMCID: PMC3302278.

124. Williams PL, Seage GR, Van Dyke RB, Siberry GS, Griner R, Tassiopoulos K, YildirimC, Read JS, Huo Y, Hazra R, Jacobson DL, Mofenson LM, and Rich K for the PediatricHIV/AIDS Cohort Study. A trigger-based design for evaluating the safety of in uteroantiretroviral exposure in uninfected children of HIV-infected mothers. Am J Epidemiol2012; 175(9):950-61. PMCID: PMC3390009.

125. McAuliffe ME, Williams PL, Korrick S, Altshul L, Perry MJ. Environmental exposure topolychlorinated biphenyls and p,p’-DDE and sperm sex chromosome disomy. Environmen-tal Health Perspectives 2012; 120(4):535-40. PMCID: PMC3339457.

126. Nachman S, Chernoff M, Williams P, Hodge J, Heston J and Gadow KD. Human immunode-ficiency virus disease severity, psychiatric symptoms, and functional outcomes in perinatallyinfected youth. Arch Pediatr Adolesc Med 2012; 166(6):528-535. PMCID: PMC3407294.

127. Braun JM, Smith K, Williams PL, Calafat AM, Berry K, Ehrlich E, and Hauser R. Vari-ability of urinary phthalate concentrations before and during pregnancy. EnvironmentalHealth Perspectives 2012; 120(5):739-45. PMCID: PMC3346778.

128. Smith R, Chernoff M, Malee KM, Williams PL, Sirois PA, Mellins CA, Wilkins M, NicholsS, and Rutstein R for the Pediatric HIV/AIDS Cohort Study. Impact of HIV severity oncognitive and adaptive functioning during childhood and adolesence. Ped Inf Dis J 2012;31(6):592-8. PMCID: PMC3424347.

129. Siberry GK, Williams PL, Mendez H, Seage III GR, Jacbson D, Hazra R, Rich K, GrinerR, Tassiopoulos K, Kacanek D, Mofenson LM, Miller T, DiMeglio L, and Watts DH forthe Pediatric HIV/AIDS Cohort Study. Safety of tenofovir use during pregnancy: earlygrowth outcomes in HIV-exposed uninfected infants. AIDS 2012; 26:151-159. PMCID:PMC3476702.

130. Ehrlich S, Williams PL, Missmer SA, Flaws JA, Berry KF, Calafat AM, Ye X, PetrozzaJ, Wright D, and Hauser R. Urinary Bisphenol A concentrations and implantation failureamong women undergoing in vitro fertilization. Environmental Health Perspectives 2012;120(7):978-93. PMCID: PMC3404656.

131. Fuller CH, Brugge D, Williams PL, Mittleman MA, Durant JL, and Spengler JD. Estima-tion of ultrafine particle concentrations at near-highway residences from local and centralmonitors. Atmospheric Environment 2012; 57:257-65. PMCID: PMC3640373.

132. Lujan-Zilberman J, Warshaw MG, Williams PL, Spector SA, Decker MD, Abzug MJ, Heck-man B, Manzella A, Kabat B, Jean-Philippe P, Nachman S, and Siberry GK for the IM-PAACT P1065 Protocol Team. Immunogenicity and safety of one versus two doses ofquadrivalent meningococcal conjugate vaccine in HIV-infected youth. Journal of Pedi-atrics 2012; 161(4):676-81,e2. PMCID: PMC3434315.

133. Gadow KD, Angelidou K, Chernoff M, Williams PL, Deygoo S, diPoalo V, Heston J, HodgeJ, Morse E, and Nachman S. Longitudinal study of emerging mental health concerns inyouth perinatally infected with HIV and peer comparisons. J Dev Behav Pediatr 2012;33(6):456-68. PMCID: PMC3520511.

134. Torre III P, Zeldow B, Hoffman HJ, Buchanan A, Siberry GK, Rice M, Sirois PA, andWilliams PL for the Pediatric HIV/AIDS Cohort Study. Hearing loss in perinatallyHIV-infected and HIV-exposed but uninfected children and adolescents. Pediatr Infect DisJ 2012; 31(8):835-41. PMCID: PMC3410657.

135. Smith KW, Braun JM, Williams PL, Ehrlich S, Berry K, Calafat AM, Xiaoyun Y, FordJ, Keller M, Meeker J, and Hauser R. Predictors and variability of urinary paraben con-centrations in men, and in women before and during pregnancy. Environmental HealthPerspectives 2012; 120(11):1538-43. PMCID: PMC3556607.

136. McAuliffe ME, Williams PL, Korrick S, Perry MJ. The association between human spermsex-chromosome disomy and semen concentration, motility, and morphology. Human Re-production 2012; 27(10):2918-26. PMCID: PMC3442635.

137. Ehrlich S, Williams PL, Missmer SA, Flaws JA, Ye X, Calafat AM, Petrozza JC, Wright D,Hauser R. Urinary Bisphenol A concentrations and early reproductive health outcomesamong women undergoing IVF. Human Reproduction 2012; 27(12):3583-92. PMCID:PMC3501244.

138. Schieffelin JS, Williams PL, Djokic D, Anderson JP, Nachman S, Oleske J, Seage III GR,and Van Dyke RB. Central nervous system vasculopathy in HIV-infected children enrolledin the Pediatric AIDS Clinical Trials Group 219/219C Study. J Ped Inf Dis 2012.

139. Watts DH, Williams PL, Kacanek D, Griner R, Rich K, Hazra R, Mofenson LM, and MendezH for the Pediatric HIV/AIDS Cohort Study team. Combination antiretroviral use andpreterm birth. J Infect Dis 2013; 207(4):612-21. PMCID: PMC3659601.

140. Lipshultz SE, Williams PL, Wilkinson JD, Leister EC, Van Dyke RB, Shearer WT, RichKC, Hazra R, Kaltman JR, Jacobson DL, Dooley L, Scott GB, Rabideau N, and Colan SDfor the Pediatric HIV/AIDS Cohort Study (PHACS). Cardiac status of children infectedwith human immunodeficiency virus who are receiving long-term combination antiretro-viral therapy: results from the Adolescent Master Protocol of the multicenter PediatricHIV/AIDS Cohort Study. JAMA Pediatr 2013; 167(6):520-7. PMCID: PMC4180681.

141. Fuller CH, Brugge D, Williams PL, Mittleman MA, Lane K, Durant JL, and Spengler JD.Indoor and outdoor measurements of particle number concentration in near-highway homes.J Expo Sci Environ Epidemiol 2013; 23(5):506-12. PMC in process.

142. Wilkinson JD, Williams PL, Leister E, Zeldow B, Shearer WG, Colan SD, Siberry GK,Dooley L, Scott GB, Rich KC and Lipshultz SE for the Pediatric HIV/AIDS Cohort Study.Cardiac biomarkers in HIV-exposed uninfected children: The Pediatric HIV/AIDS CohortStudy (PHACS). AIDS 2013; 27(7):1099-1108. PMCID: PMC4142694.

143. Sirois PS, Huo Y, Williams PL, Malee KM, Garvie PA, Kammerer B, Rich K, and Nozyce MLfor the Pediatric HIV/AIDS Cohort Study. Safety of perinatal exposure to antiretroviralmedications on developmental outcomes in infants. Pediatr Infect Dis J 2013; 32:648-55.PMCID: PMC3723344.

144. Humblet O, Korrick S, Williams PL, Sergeyev O, Emond C, Birnbaum LS, Burns JS, AltshulL, Patterson Jr DG, Turner WE, Lee MM, Revich B, and Hauser R. Genetic modificationof the association between peripubertal dioxin exposure and pubertal onset in a cohort ofRussian boys. Environ Health Perspect 2013; 121(1):111-117. PMCID: PMC3546349.

145. Fleisch AF, Burns JS, Williams PL, Lee MM, Sergeyev O, Korrick SA, and Hauser R.Blood lead levels and serum insulin-like growth factor 1 concentrations in peripubertalboys. Environ Health Perspect 2013; 121(7):854-8. PMCID: PMC3702001.

146. Williams PL, Abzug MJ, Jacobson DL, Wang J, Van Dyke RB, Hazra R, Patel K, DiMeglioLA, McFarland EJ, Silio M, Borkowsky W, Seage GR, Oleske JM, and Geffner ME for theInternational Maternal Pediatric and Adolescent AIDS Clinical Trials P219/219C Studyand the Pediatric HIV/AIDS Cohort Study. Pubertal onset in children with perinatal HIVinfection in the era of combination antiretroviral treatment. AIDS 2013; 27(12):1959-70.PMCID: PMC4143250.

147. Palmsten K, Huybrechts KF, Michels KB, Williams PL, Mogun H, Setoguchi S, Hernndez-Daz S. Antidepressant use and risk for preeclampsia among women enrolled in Medicaid.Epidemiology 2013; 24(5):682-91. PMCID: PMC4159745.

148. Afeiche M, Williams PL, Mendiola J, Gaskins AJ, Jorgensen N, Swan SH, Chavarro JE.Dairy food intake in relation to semen quality and reproductive hormones among physicallyactive young men. Human Reproduction 2013; 28(8):2265-75. PMCID: PMC3712661.

149. Williams PL, Chernoff M, Angelidou K, Brouwers P, Kacanek D, Deygoo NS, Gadow KD,and Nachman S for the IMPAACT P1055 Study Team. Participation and retention of youthwith perinatal HIV infection in mental health research studies: the IMPAACT P1055 Psy-chiatric Comorbidity Study Journ Acquir Immune Defic Syndr 2013; 63(3):401-9. PMCID:PMC3683105.

150. Smith KW, Souter I, Dimitriadis I, Ehrlich S, Williams PL, Calafat A, Hauser R. Urinaryparaben concentrations and ovarian aging among women from a fertility center. EnvironHealth Perspect 2013; 121:1299-1305. PMCID: PMC3855500.

151. Spector SA, Qin M, Lujan-Zilberman J, Singh KK, Warshaw MG, Williams PL, Jean-Philippe P, Fenton T, and Siberry GK for the IMPAACT P1065 Protocol Team. Geneticvariants in TLR-2, -4, and -9 and FC γ RII are associated with antibody response to thequadrivalent meningococcal conjugate vaccine in HIV-infected youth. Clinical and VaccineImmunology 2013; 20(6):900-6. PMCID: PMC3675972.

152. Rice ML, Zeldow B, Siberry GK, Purswani M, Malee K, Hoffman HJ, Frederick T, BuchananA, Sirois PA, Allison SM, Williams PL for the Pediatric HIV/AIDS Cohort Study. Evalu-ation of risk for late language emergence after in utero antiretroviral drug exposure. PediatrInf Dis J 2013; 32(10):e406-413. PMCID: PMC3785009.

153. Palmsten K, Huybrechts KF, Mogun H, Kowal MK, Williams PL, Michels KB, SetoguchiS, Hernandez-Diaz S. Harnessing the Medicaid Analytic eXtract (MAX) to evaluate med-ications in pregnancy: design considerations. PLOS One 2013; 8(6):e67405. PMCID:PMC3693950.

154. Ehrlich S, Williams PL, Hauser R, Missmer SA, Peretz J, Calafat AM, Flaws JA. Urinarybisphenol A concentrations and cytochrome P450 19 A1(Cyp19) gene expression in ovar-ian granulosa cells: an in vivo human study. Reproductive Toxicology 2013; 42C:18-23.PMCID: PMC3836875.

155. Lam T, Williams PL, Burns JS, Sergeyev O, Birnbaum LS, Revich B, Hauser R. Predictors ofserum concentrations of chlorinated pesticides among peri-pubertal Russian boys. EnvironHealth Perspect 2013; 121:1372-77. PMCID: PMC3855511.

156. Machtinger R, Combelles C, Missmer S, Correia K, Williams P, Hauser R, Racowsky C.Bisphenol A (BPA) and human oocyte maturation in-vitro. Human Reproduction 2013;28(10):2735-45. PMCID: PMC3777571.

157. Palmsten K, Hernandez-Diaz S, Huybrechts KF, Williams PL, Michels KB, Achtyes ED,Mogun H, and Setoguchi S. Use of antidepressants near delivery and risk for postpar-tum hemorrhage: cohort study of low income women in the United States. BMJ 2013;347:f4877. PMCID: PMC3748906.

158. Ransom CE, Huo Y, Patel K, Scott GB, Watts H, Williams P, Siberry G, Livingston E forthe P1025 Team of the International Maternal Pediatric Adolescent AIDS Clinical TrialsGroup. Association of tenofovir disoproxil fumarate with neonatal growth. Journ AcquirImmun Defic Syndr 2013; 64(4):374-81. PMCID: PMC3818710.

159. Souter I, Smith KW, Dimitradis I, Ehrlich S, Williams PL, Calafat AM, Hauser R. The asso-ciation of bisphenol-A urinary concentrations with antral follicle counts and other measuresof ovarian reserve in women undergoing infertility treatments. Reproductive Toxicology2013; 42:224-31. PMCID: PMC4383527.

160. Braun JM, Just AC, Williams PL, Smith K, Calafat AM, and Hauser R. Personal care prod-uct use and urinary phthalate metabolite and paraben concentrations during pregnancyamong women from a fertility clinic. J Expo Sci Environ Epidemiol 2014; 24(5):459-66.PMCID: PMC4016195.

161. Kapetanovic S, Griner R, Zeldow B, Nichols S, Leister E, Gelbard HA, Miller TL, HazraR, Mendez AJ, Malee K, Kammerer B, and Williams PL for the Pediatric HIV/AIDSCohort Study team. Biomarkers and neurodevelopment in perinatally HIV-infected orexposed youth: A structural equation model analysis. AIDS 2014; 28(3):355-64. PMCID:PMC4191846.

162. Maity A, Williams PL, Ryan L, Missmer S, and Hauser R. Discrete time to event analysiswith multiple outcomes with an appplication to in vitro fertilization data. Statistics inMedicine 2014; 33(10):1738-49. PMCID: PMC3981885.

163. Anderson JP, Tchetgen Tchetgen EJ, Lo Re III V, Tate JP, Williams PL, Seage III GR,Horsburgh CR, Lim JK, Goetz MD, Rimland D, Rodriguez-Barradas MD, Butt AA, Klein

MB, Justice AC. Antiretroviral therapy reduces the rate of hepatic decomposition in hep-atitis C virus-coinfected veterans. Clinical Infectious Disease 2014; 58(5):719-27. PMCID:PMC3922212.

164. Malee K, Mellins C, Huo Y, Tassiopoulos K, Smith R, Sirois P, Allison S, Kacanek D,Kapetanovic S, Williams P, Grant M, Marullo D, and Aidala A for the Pediatric HIV/AIDSCohort Study (PHACS). Prevalence, incidence and persistence of psychiatric and substanceuse disorders among mothers living with HIV. Journ Acquir Immun Defic Syndr 2014;65(5):526-34. PMCID: PMC3999478.

165. Afeiche M, Williams PL, Gaskins AJ, Mendiola J, Jorgensen N, Swan SH, Chavarro JE. Meatintake and reproductive parameters among physically active young men. Epidemiology2014; 25(3):323-330. PMCID: PMC4180720.

166. Phiri K, Hernandez-Diaz S, Dugan KB, Williams PL, Dudley JA, Jules A, Callahan SG,Seage GR III, and Cooper WO. First trimester exposure to antiretroviral therapy and riskof birth defects. Ped Inf Dis J 2014; 33(7):741-6. PMCID: PMC4420801.

167. Patel K, Wang J, Jacobson DL, Lipshultz SE, Landy DC, Geffner ME, DiMeglio LA, SeageIII GR, Williams PL, VanDyke RB, Siberry GK, Shearer WT, Young L, Scott GB,Wilkinson JD, Fisher SD, Starc TJ, and Miller TL for the Pediatric HIV/AIDS CohortStudy. Aggregate risk of cardiovascular disease among adolescents perinatally infectedwith the Human Immunodeficiency Virus. Circulation 2014; 129(11):1204-12. PMCID:PMC3991841.

168. Phiri K, Fischer MA, Mogun H, Williams PL, Palmsten K, Seage GR III, and Hernandez-Diaz S. Trends in antiretroviral drug use during pregnancy among HIV-infected pregnantwomen on Medicaid: 2000 to 2007. AIDS Patient Care and STDs 2014; 28:56-65. PMCID:PMC3926172.

169. Afeiche MC, Bridges ND, Williams PL, Gaskins AJ, Tanrikut C, Petrozza JC, Hauser R,and Chavarro JE. Dairy intake and semen quality among men attending a fertility clinic.Fertility and Sterility 2014; 101(5):1280-7. PMCID: PMC4008690.

170. Garvie PA, Zeldow B, Malee K, Nichols S, Smith RA, Wilkins ML, and Williams PL for thePediatric HIV/AIDS Cohort Study. Discordance of cognitive and academic achievementoutcomes in youth with perinatal HIV exposure. Ped Inf Dis J 2014; 33(9): e232-238.PMCID: PMC4217131.

171. Nozyce ML, Huo Y, Williams PL, Kapetanovic S, Hazra R, Nichols S, Hunter S, SmithR, Seage III GR, Sirois PA for the Pediatric HIV/AIDS Cohort Study. Safety of in uteroand neonatal ARV exposure: cognitive and academic outcomes in HIV-exposed uninfectedchildren age 5-13 years. Ped Inf Dis J 2014; 33:1128-33. PMCID: PMC4217087.

172. Chiu Y-H, Aefiche M, Gaskins AJ, Williams PL, Mendiola J, Jorgensen N, Swan SH, andChavarro JE. Sugar-sweetened beverage intake in relation to semen quality and reproduc-tive hormone levels in young men. Human Reproduction 2014; 29(7):1575-84. PMCID:PMC4168308.

173. Afeiche MC, Gaskins AJ, Williams PL, Toth T, Wright D, Tanrikut C, Hauser R, andChavarro JE. Processed meat intake is unfavorably and fish intake favorably associatedwith semen quality indicators among men attending a fertility clinic. Journal of Nutrition2014; 144(7):1091-8. PMCID: PMC4056648.

174. Gaskins AJ, Rich-Edwards JW, Hauser R, Williams PL, Gillman MW, Ginsburg ES, Miss-mer SA, and Chavarro JE. Maternal pre-pregnancy folate intake and risk of spontaneousabortion and stillbirth. Obstetrics and Gynecology 2014; 124(1):23-31. PMCID: PMC4086728.

175. Lam T, Williams PL, Lee MM, Korrick SA, Birnbaum LS, Burns JS, Sergeyev O, RevichB, Althshul M, Patterson DG, Turner WE, and Hauser R. Prepubertal organochlorinepesticide concentrations and age of pubertal onset among Russian boys. EnvironmentInternational 2014; 73:135-42. PMCID: PMC4194160.

176. Burns JS, Williams PL, Korrick S, Hauser R, Sergeyev O, Revich B, Lam T and Lee MM.Association between chlorinated pesticides in the serum of prepubertal Russian boys andlongitudinal biomarkers of metabolic function. Am Journ Epidemiol 2014; 180(9):909-19.PMCID: PMC4207719.

177. McAuliffe ME, Williams PL, Korrick S, Dadd R, Marchetti F, Martenies SE, Perry MJ.Human sperm sex chromosome disomy and sperm DNA damage assessed by the neutralcomet assay. Human Reproduction 2014; 29(10):2148-55. PMCID: PMC4163795.

178. Gaskins AJ, Rich-Edwards JW, Hauser R, Williams PL, Gillman MW, Penzias A, MissmerSA, and Chavarro JE. Pre-pregnancy dietary patterns and risk of pregnancy loss. Am JClin Nutr 2014; 100(4):1166-72. PMCID: PMC4163795.

179. Gaskins AJ, Afeiche MC, Hauser R, Williams PL, Gillman MW, Tanrikut C, Petrozza JC,and Chavarro JE. Paternal physical and sedentary activities in relation to semen qualityand reproductive outcomes among couples from a fertility center. Human Reproduction2014; 29(11):2575-82. PMCID: PMC4191451.

180. Williams PL, Crain M, Yildirim C, Hazra R, Van Dyke RB, Rich K, Read JS, StuardE, Rathore M, Mendez HA, Watts DH. Congenital anomalies and in utero antiretroviralexposure in human immunodeficiency virus-exposed uninfected infants. JAMA Pediatrics2015; 169(1):48-55. PMCID: PMC4286442.

181. Gaskins AJ, Afeiche M, Wright DL, Toth TL, Williams PL, Gillman MW, Hauser R, andChavarro JE. Dietary folate and reproductive success among women undergoing assistedreproduction: a prospective cohort study. Obstetrics and Gynecology 2014; 124(4):801-9.PMCID: PMC4172634.

182. Lipshultz SE, Williams PL, Zeldow B, Wilkinson JD, Rich K, VanDyke RB, Seage GRIII, Dooley LB, Kaltman JR, Siberry G, Mofenson LM, Shearer WT, and Colan SD forthe Pediatric HIV/AIDS Cohort Study (PHACS). Cardiac effects of in utero exposure toantiretroviral therapy in HIV-uninfected children born to HIV-infected mothers. AIDS2015;29:91-100. PMCID: PMC4287991.

183. Torre III P, Yao TJ, Zeldow B, Williams PL, Hoffman HJ, Siberry G, for the PediatricHIV/AIDS Cohort Study. Distortion product otoacoustic emission data in perinatallyHIV-Infected and HIV-exposed but uninfected children and adolescents in the PediatricHIV/AIDS Cohort Study. Ped Inf Dis J 2014; 34(3):276-8. PMCID: PMC4365792.

184. Crowell CS, Huo Y, Tassiopoulos K, Malee KM, Yogev R, Hazra R, Rutstein RM, NicholsSL, Smith R, Williams PL, Oleske J, Muller WJ for the PACTG 219C Study Teamand the Pediatric HIV/AIDS Cohort Study (PHACS). Early viral suppression improvesneurocognitive outcomes in HIV-infected children. AIDS 2015; 29(3): 295-304. PMCID:PMC4332557.

185. Dodge LE, Williams PL, Williams MA, Missmer SA, Toth TL, Calafat AM, Hauser R.Paternal urinary concentrations of parabens and other phenols in relation to reproductiveoutcomes among couples from a fertility center. Env Health Perspect 2015; 123(7):665-71.PMCID: PMC4492268.

186. Vanegas JC, Afeiche MC, Gaskins AJ, Minguez-Alarcon L, Williams PL, Wright DL, TothTL, Hauser R, and Chavarro JE. Soy food intake and treatment outcomes of women un-dergoing assisted reproductive technology. Fertility and Sterility 2015; 103(3): 749-755.PMCID: PMC4346414.

187. Wright DL, Afeiche MC, Ehrlich S, Smith K, Williams PL, Chavarro JE, Batsis M, TothTL, Hauser R. Hair mercury concentrations and in vitro fertilization (IVF) outcomesamong women from a fertility clinic. Reproductive Toxicology 2015; 51C: 125-32. PM-CID: PMC4425999.

188. Phiri K, Williams PL, Dugan KB, Fischer MA, Cooper WO, Seage GR III, and Hernandez-Diaz S. Antiretroviral therapy use during pregnancy and the risk of small-for-gestational-age birth in a Medicaid population. Ped Inf Dis J 2015; 34(7):e169-75. PMCID: PMC4466082.

189. Krogstad P, Patel K, Karalius B, Hazra R, Abzug MJ, Oleske J, Seage GR III, Williams PL,Borkowsky W, Wiznia A, Pinto J, and Van Dyke RB for the Pediatric HIV/AIDS CohortStudy, IMPAACT 219C, and NICHD International Site Development Initiative (NISDI)Investigators. Incomplete immune reconstitution despite virological suppression in HIV-1infected children and adolescents. AIDS 2015; 29(6):683-693. PMCID: PMC4391276.

190. Chiu YH, Afeiche MC, Gaskins AJ, Williams PL, Petrozza JC, Tanrikut C, Hauser R,and Chavarro JE. Fruit and vegetable intake and their pesticide residues in relation tosemen quality among men from a fertility clinic. Human Reproduction 2015; 30(6):1342-51.PMCID: PMC4447887.

191. Dodge LE, Kelley KE, Williams PL, Williams MA, Hernandez-Diaz S, Missmer SA, HauserR. Medications as a source of paraben exposure among women and men of reproductiveage. Reproductive Toxicology 2015; 52:93-100. PMCID: PMC4426043.

192. Anderson JP, Horsburgh RC, Williams PL, Tchetgen Tchetgen E, Nunes D, Cotton D,Seage III GR. CD4 recovery on ART is associated with decreased progression to liverdisease among hepatitis C virus-infected injecting drug users. Infectious Disease OpenForum 2015; 2(1):ofv019. PMCID: PMC4438899.

193. Fuller CH, Williams PL, Mittleman MA, Patton A, Spengler JD, and Brugge D. Responseof biomarkers of inflammation and coagulation to short-term changes in central site, localand predicted particle number concentrations. Annals of Epidemiology 2015; 25(7):505-11.PMCID: PMC4457635

194. Uban KA, Herting MM, Williams PL, Ajmera T, Gautam P, Huo Y, Malee KM, Yogev R,Csernansky JG, Wang L, Nichols SL, Van Dyke RB, Sowell ER for the Pediatric HIV/AIDSCohort Study. White matter microstructure among youth with perinatally acquired HIVis associated with disease severity. AIDS 2015; 29(9):1035-44. PMCID: PMC4487416

195. Himes SK, Huo Y, Siberry GK, Williams PL, Rice ML, Sirois PA, Frederick T, Hazra R,Huestis MA: Pediatric HIV/AIDS COhort Study (PHACS). Meconium atazanavir con-centrations and early language outcomes in HIV-exposed uninfected infants with prenatalatazanavir exposure. J Acquir Immune Defic Syndr 2015; 69(2):178-86.

196. Kacanek D, Angelidou K, Williams PL, Chernoff M, Gadow K, and Nachman S for the In-ternational Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1055 StudyTeam. Psychiatric symptoms and antiretroviral non-adherence in US youth with perinatalHIV infection: A longitudinal study. AIDS 2015; 29(10):1227-37. PMCID: PMC4526219.

197. Minguez-Alarcon L, Afeiche MC, Chiu YH, Vanegas JC, Williams PL, Tanrikut C, TothTL, Hauser R, and Chavarro JE. Male soy food intake was not associated with in vitrofertilization outcomes among their partners attending a fertility center. Andrology 2015;3(4):702-8. PMCID: PMC4693610.

198. Lam T, Williams PL, Lee MM, Korrick S, Birnbaum LS, Burns J, Sergeyev O, RevichB, Altshul L, Patterson DG, Hauser R. Prepubertal serum concentrations of organochlo-rine pesticides and age at sexual maturity in Russian boys. Env Health Perspect 2015;123(11):1216-21. PMCID: PMC4629743.

199. Hauser R, Gaskins AJ, Souter I, Smith KW, Dodge L, Ehrlich S, Meeker JD, Calafat AM,Williams PL. Urinary phthalate metabolite concentrations and reproductive outcomesamong women undergoing in vitro fertilization: Results from the EARTH study. EnvHealth Perspect 2015; Nov 6 [Epub ahead of print].

200. Xia W, Chiu YH, Williams PL, Gaskins AJ, Toth TL, Tanrikut C, Hauser R, and ChavarroJE. Men’s meat intake and treatment outcomes among couples undergoing assisted repro-duction. Fertility and Sterility 2015; 104(4):972-9. PMCID: PMC4592805.

201. Minguez-Alarcon L, Gaskins AJ, Chiu YH, Williams PL, Petrozza JC, Calafat AM, EhrlichS, Chavarro JE, Ford J, Hauser R for the EARTH Study Team. Urinary bisphenol A levelsand associations with in vitro fertilization (IVF) outcomes among women from a fertilityclinic. Human Reproduction 2015; 30(9):2120-8. PMCID:PMC4542722

202. Herting MM, Uban KA, Williams PL, Gautam P, Yuo Y, Malee K, Yogev R, CsernanskyJ, Wang L, Nichols, Van Dyke R, Sowell ER. Default mode connectivity in youth withperinatally-acquired HIV. Medicine 2015; 94(37):e1417. PMCID: PMC4635795

203. Mirani G*, Williams PL*, Chernoff M, Abzug MJ, Levin MJ, Seage III GR, Oleske JM,Purswani MU, Hazra R, Traite S, Zimmer B, VanDyke RB for the IMPAACT P1074 StudyTeam. Changing trends in complications and morality among US youth and young adultswith HIV infection in the era of combination antiretroviral therapy. (*: co-first authors).Clin Infect Dis 2015; 61(12):1850-61. PMCID: PMC4657532.

204. Gaskins AJ, Chiu YH, Williams PL, Toth TL, Hauser R, Chavarro JE. Association betweenserum folate and vitamin B12 and success of assisted reproductive technologies. Am J ClinNutr 2015; 102(4):943-50. PMCID:PMC4588741

205. Sirois PA, Aaron L, Montepiedra G, Pearson DA, Kapetanovic S, Williams PL, Garvie PA,Nozyce M, Malee K, Nichols SL, Kammerer BL, Mitchell WG, Mintz M, and Oleske JM forthe IMPAACT/PACTG 219C Team. Stimulant medications and cognition, behavior, andquality of life in children and youth with HIV. Ped Inf Dis J 2016; 35(1):e12-18. PMCID:PMC4705843.

206. Williams PL, Hazra R, Van Dyke RB, Yildirim C, Crain MJ, Seage III GR, Civitello L, EllisA, Butler L, Rich K for the Pediatric HIV/AIDS Cohort Study. Antiretroviral exposureduring pregnancy and adverse outcomes in HIV-exposed uninfected infants and childrenusing a trigger-based design. AIDS 2015; 30(1):133-44. PMCID:PMC4704129.

207. Messerlian C, Souter I, Gaskins A, Williams PL, Ford J, Chiu YH, Calafat R for the EARTHStudy. Urinary phthalate metabolites and ovarian reserve among women seeking infertilitycare. Human Reproduction 2016; 31(1):75-83. PMCID: PMC4677966.

208. Chiu YH, Afeiche MC, Gaskins AJ, Williams PL, Petrozza JC, Tanrikut C, Hauser R, andChavarro JE. Pesticide residues and semen quality. Human Reproduction 2015; 30(9):2241-2. (letter)

209. Dodge LE, Williams PL, Williams MA, Missmer SA, Souter I, Calafat AM, and Hauser R.Associations between paternal urinary phthalate metabolite concentrations and reproduc-tive outcomes among couples seeking fertility treatment. Reprod Toxicol 2015; 58:184-193.PMCID: PMC4690752.

210. Kirmse B, Yao TJ, Hofherr S, Kacanek D, Williams PL, Hobbs C, Hazra R, Borkowsky W,Van Dyke RB, Summar M for the Pediatric HIV/AIDS Cohort Study (PHACS). Abnormalfatty acid oxidation in HIV-exposed, uninfected neonates in the United States. AIDSResesarch and Human Retroviruses 2016; Jan 19 [Epub ahead of print].

211. Minguez-Alarcon L, Chiu YH, Messerlian C, Williams PL, Sabatini ME, Toth TL, Ford JF,Calafat AM, Hauser R. Urinary paraben concentrations and in vitro fertilization outcomesamong women from a fertility clinic. Fertility and Sterility 2015; Dec 2 [Epub ahead ofprint].

212. Nichols SL, Chernoff MC, Malee K, Sirois P, Williams PL, Figeroa V, Woods S. Learningand memory in children and adolescents with perinatal HIV infection. Ped Inf Dis J 2016;in press.

213. Xia W, Chiu YU, Afeiche MC, Williams PL, Ford JB, Tanrikut C, Souter I, Hauser R,Chavarro JE for the EARTH Study Team. Impact of men’s dairy intake on assisted repro-ductive technology outcomes among couples attending a fertility clinic. Andrology 2016;PMID: 26825777.

214. Kapogiannis B, Leister E, Siberry GK, Van Dyke RB, Rudy B, Flynn P, Williams PL.Prevalence of and progression to abnormal non-invasive markers of liver diasease (APRIand FIB-4) among US HIV-infected youth. AIDS 2015; in press.

215. Chavarro JE, Mnguez-Alarcn L, Chiu YH, Gaskins AJ, Souter I, Williams PL, Calafat AM,Hauser R for the EARTH Study team. Soy intake modifies the relation between urinarybisphenol A concentrations and in vitro fertilization outcomes. J Clin Endocrinol Metab2016; Jan 27 [Epub ahead of print].

216. Messerlian C, Wylie BJ, Minguez-Alarcon L, Williams PL, Ford JB, Calafat AM, HauserR for the EARTH STudy Team. Urinary phthalate metabolite concentration in relation topregnancy loss among women conceiving with medically assisted reproduction. Epidemi-ology 2016; in press.

217. Afeiche MC, Chiu YH, Gaskins AJ, Williams PL, Souter I, Wright D, Hauser R, ChavarroJE for the EARTH Study Team. Dairy intake in relation to in vitro fertilization outcomesamong women from a fertility clinic. Human Reproduction 2016; 31(3):563-71. PMCID:PMC4755446.

218. Fisher SD, Starc TJ, Guerra V, Williams PL, Wilkinson J, Lipshultz SE. Declining incidenceof systolic left ventricular dysfunction in HIV-Infected individuals treated with highly activeantiretroviral therapy. Am J Cardiol 2016; Ii press.

219. Guerra V, Leister EC, Williams PL, Starc TJ, Lipshultz SE, Wilkinson JD, VanDyke RB,Hazra R, and Colan SD for the Pediatric HIV/AIDS Cohort Study. Long-term effects ofin utero antiretroviral exposure: systolic and diastolic function in HIV-exposed uninfectedyouth. AIDS Research and Human Retroviruses 2016; Jan 21 [Epub ahead of print].

220. Caniglia EC, Patel K, Huo Y, Williams PL, Kapetanovic S, Rich K, Sirois PA, JacobsonDA, Hernandez-Diaz S, Hernan MA, Seage III GR for the Pediatric HIV/AIDS CohortStudy. Atazanavir exposure in utero and neurodevelopment in infants: A comparativesafety study. AIDS 2016; Feb 22 [ Epub ahead of print]

221. Gaskins AJ, Chiu HY, Williams PL, Keller MG, Toth TL, Hauser R, Chavarro JE for theEARTH Study Team. Whole grain intake and outcomes of in vitro fertiliziation. Fertilityand Sterility 2016; in press.

222. Gaskins AJ, Rich-Edwards JW, Williams PL, Toth TL, Missmer SA, Chavarro JE. Prepreg-nancy low to moderate alcohol intake is not associated with risk of spontaneous abortionor stillbirth. Journal of Nutrition 2016; in press.